跳至主要内容
临床试验/EUCTR2010-020303-69-NL
EUCTR2010-020303-69-NL进行中(未招募)不适用

Enzyme substitution in exocrine pancreatic insufficiency; Self administration against a fixed dose regimen. - SAPES

Erasmus MC0 个研究点目标入组 20 人开始时间: 2011年9月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Erasmus MC
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients who are considered for this trial:
  • -are older than 18 years.
  • -suffer from EPI caused by CP.
  • -Fecal elastase < 0.200 mg/g
  • -are using = 6 capsules of 25.000 FIP-E units of lipase per day.
  • -fecal fat-absorption < 85% without using enzymes.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • The following are considered as exclusion criteria:
  • - Subjects who are unwilling or unable to understand and participate in the study and/or sign the informed consent.
  • -Any known gastro-intestinal disease or major gastrointestinal or pancreatic surgery that could potentially affect the intestinal absorption or metabolism of fat
  • -Gastroparesis of any aetiology
  • -Hypersensitivity to pork protein
  • -Acute pancreatitis
  • -Limited life-expectancy of = 6 months
  • -Malignancy of the pancreas
  • -Pregnancy/lactation

研究者

发起方
Erasmus MC

相似试验